Skip to main content

Chronic Obstructive Pulmonary Disease

Hightower’s COPD clinical trial is exploring innovative methods for improving respiratory health for all.

Breathe Better

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent respiratory condition affecting millions globally. Individuals with COPD experience challenges such as shortness of breath, coughing, and wheezing, impacting their daily activities and quality of life. Hightower Clinical, renowned for its medical innovations, understands the complexities of COPD management.

With a dedicated team, Hightower is actively engaged in developing groundbreaking therapies tailored for COPD patients.

The need for novel treatments for COPD is critical, considering the limitations of current interventions in providing comprehensive relief. Hightower’s strategic focus involves pioneering approaches that target COPD’s underlying mechanisms, aiming to alleviate symptoms, enhance lung function, and improve overall respiratory health.


Chronic Obstructive Pulmonary Disease

Current Status




Frequently Asked Questions

Are there any compensation or reimbursements for participating in a clinical trial?

While the primary focus is not financial gain, some trials may offer compensation for your time and travel costs associated with study visits.

Will I be able to continue taking my current medications if I participate in a clinical trial?

It depends on the specific trial. The professional physician investigators will discuss any potential conflicts with your current medications during the screening process.

How long will the results of the clinical trial be available?

The timeframe for obtaining results varies depending on the trial design and research goals. The research team will provide an estimated timeline for when you might expect preliminary or final findings.)